Navigation Links
Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
Date:9/13/2010

ther studies may not proceed at the time or in the manner Arena or others expect or at all; Arena's ability to obtain adequate funds; Arena's ability to obtain and defend its patents; and the timing and receipt of payments and fees, if any, from Eisai and Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.Contact: Arena Pharmaceuticals, Inc.

Media Contact: Russo PartnersJack Lief

David Schull, PresidentPresident and CEO

david.schull@russopartnersllc.com858.717.2310Cindy McGeeManager, IR and Corporate Communications

Anthony J. Russo, Ph.D., CEO858.453.7200, ext. 1479

tony.russo@russopartnersllc.com212.845.4251
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
2. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
3. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
4. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
5. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
6. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
7. Arena Pharmaceuticals to Host Conference Call and Webcast on Friday, September 18, 2009, to Discuss Results from the BLOSSOM Phase 3 Trial of Lorcaserin for Weight Management
8. Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
9. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
10. Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... -- Moms are ready to live the "measured life" ... kids, according to the results of the BabyCenter® U.S. ... for Moms, the latest installment in BabyCenter,s 21 st ... and parenting web and mobile destination worldwide, conducted the ... say they can,t think of a reason not to ...
(Date:10/22/2014)... Oregon , October 22, 2014 ... "Global Disposable Gloves Market (Product type, Form, End user, ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... global disposable gloves market. Based on key trends tracked, ... be valued at $7.9 billion by 2020, registering a ...
(Date:10/22/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... focused on the development of oral drug delivery ... its Phase IIa clinical trial of ORMD-0801, the ... 1 diabetes. The trial was conducted in ... Food and Drug Administration (FDA) Investigational New Drug ...
Breaking Medicine Technology:BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 3BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 4Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4
...  Brainlab, a leader in software-driven medical technology, announced today ... at the University of California San Francisco (UCSF) Medical ... advanced neurosurgery procedures to help detect and remove brain ... is one of the top hospitals in the nation ...
... 2012  Lilly Diabetes and Walgreens are educating people ... common and misunderstood consequences of diabetes: hypoglycemia (low ... campaign at 43 Walgreens pharmacies throughout the Indianapolis ... about hypoglycemia that pharmacists may use when counseling ...
Cached Medicine Technology:UCSF Medical Center Treats Patients with New Brainlab Curve™ Image Guided Surgery 2UCSF Medical Center Treats Patients with New Brainlab Curve™ Image Guided Surgery 3Lilly Diabetes and Walgreens Launch Diabetes Hypoglycemia Awareness Campaign 2Lilly Diabetes and Walgreens Launch Diabetes Hypoglycemia Awareness Campaign 3
(Date:10/25/2014)... News) -- Arriving home safe and sound is one of ... be sure that costumes and goody bags have reflective strips ... emergency medicine doctor at Meadowlands Hospital Medical Center in Secaucus, ... costumes should be flame-resistant, Davis said. He offers these ... test it on a small area of skin first to ...
(Date:10/25/2014)... 2014 Market Research Report ... 2009-2019 is a professional and in-depth market ... industry. The report firstly reviews the basic ... application and manufacturing technology. The report then ... Molecular Diagnostics listing their product specification, capacity, ...
(Date:10/25/2014)... Limbkeepers® announced today that they will be ... Begley Jr, airing 1st QTR 2015 via Discovery Channel. ... Innovations will focus on Limbkeepers® non compression knit sleeves, ... on arms, hands, and legs from abrasion, skin tears ... which help reduce injuries, allow for continued daily activities, ...
(Date:10/25/2014)... 2014 (HealthDay News) -- A large influx of international ... to avoid tens of thousands of deaths from the ... predict. Using a specially designed mathematical model, ... outbreak in just one densely populated county of hard-hit ... of Monrovia. The researchers said that if international ...
(Date:10/22/2014)... On Saturday, October 25, 2014, the Brownsville Community ... and fitness fair ¡Vive tu vida! Get Up! Get Moving!®. ... for better health and wellness for people of all ages ... to the public, will be held at Dean Porter Park, ... 1:00 pm. , “¡Vive tu Vida! Get Up! Get ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4
... (Boston) - Boston Medical Center (BMC) has been awarded ... Heart, Lung and Blood Institute (NHLBI) for investigators from ... Center for Health Insurance Reform, Cardiovascular Outcomes and Disparities. ... understand the effects of Massachusetts health reform on cardiovascular ...
... Kang Zhang, MD, PhD, professor of ophthalmology at the ... director of UCSD,s Institute of Genomic Medicine, has been ... Zhang and co-principal investigators Sheng Ding, PhD, from ... the University of Washington, received the highest possible scores ...
... HOUSTON - Patients with triple negative breast cancer that also ... lower risk of recurrence, compared to those with the same ... The University of Texas MD Anderson Cancer Center. The ... in this select group of triple negative breast cancer patients, ...
... By Steven Reinberg HealthDay Reporter , ... anti-inflammatory drug dexamethasone along with antibiotics increases the ... Dutch researchers report. "Dexamethasone therapy reduces mortality ... Dr. Diederik van de Beek, a clinical neurologist ...
... headed by Washington University School of Medicine in,St. ... heart and lung diseases that use,nanotechnology. The ... Institute, will fund five years of research at ... University of Texas Southwestern Medical Center, and the ...
... of researchers led by a Michigan State University scientist has ... cancer in young women, focusing on growth, diet, physical activity ... The five-year study, funded by the National Institutes of Health ... Medicine,s Department of Epidemiology, will include the largest sample in ...
Cached Medicine News:Health News:Researchers to study effects of Mass. health reform 2Health News:UCSD receives NIH Transformative R01 Award for stimulation of neuron regeneration in the retina 2Health News:UCSD receives NIH Transformative R01 Award for stimulation of neuron regeneration in the retina 3Health News:Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence 2Health News:Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence 3Health News:Anti-Inflammatory Helps Treat Bacterial Meningitis: Study 2Health News:Anti-Inflammatory Helps Treat Bacterial Meningitis: Study 3Health News:WUSTL awarded $18 million to treat heart, lungs with nanotechnology 2Health News:WUSTL awarded $18 million to treat heart, lungs with nanotechnology 3Health News:MSU researcher awarded $14 million to identify breast cancer risk factors 2
Lead filled and faced bone mallet used to exert force on osteotomes, chisels, and gouges....
Straight curette with hollow handle and round cup....
Coarse rasp....
Rasp with down cutting pattern....
Medicine Products: